Literature DB >> 11777965

IL-1 beta enhances CD40 ligand-mediated cytokine secretion by human dendritic cells (DC): a mechanism for T cell-independent DC activation.

Thomas Luft1, Michael Jefford, Petra Luetjens, Hubertus Hochrein, Kelly-Anne Masterman, Charlie Maliszewski, Ken Shortman, Jonathan Cebon, Eugene Maraskovsky.   

Abstract

CD40 ligand (CD40L) is a membrane-bound molecule expressed by activated T cells. CD40L potently induces dendritic cell (DC) maturation and IL-12p70 secretion and plays a critical role during T cell priming in the lymph nodes. IFN-gamma and IL-4 are required for CD40L-mediated cytokine secretion, suggesting that T cells are required for optimal CD40L activity. Because CD40L is rapidly up-regulated by non-T cells during inflammation, CD40 stimulation may also be important at the primary infection site. However, a role for T cells at the earliest stages of infection is unclear. The present study demonstrates that the innate immune cell-derived cytokine, IL-1beta, can increase CD40L-induced cytokine secretion by monocyte-derived DC, CD34(+)-derived DC, and peripheral blood DC independently of T cell-derived cytokines. Furthermore, IL-1beta is constitutively produced by monocyte-derived DC and monocytes, and is increased in response to intact Escherichia coli or CD40L, whereas neither CD34(+)-derived DC nor peripheral blood DC produce IL-1beta. Finally, DC activated with CD40L and IL-1beta induce higher levels of IFN-gamma secretion by T cells compared with DC activated with CD40L alone. Therefore, IL-1beta is the first non-T cell-derived cytokine identified that enhances CD40L-mediated activation of DC. The synergy between CD40L and IL-1beta highlights a potent, T cell-independent mechanism for DC activation during the earliest stages of inflammatory responses.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11777965     DOI: 10.4049/jimmunol.168.2.713

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  32 in total

Review 1.  A virological view of innate immune recognition.

Authors:  Akiko Iwasaki
Journal:  Annu Rev Microbiol       Date:  2012       Impact factor: 15.500

2.  Cramoll 1,4 lectin increases ROS production, calcium levels, and cytokine expression in treated spleen cells of rats.

Authors:  Cristiane Moutinho Lagos de Melo; Bruno Alves Paim; Karina Gotardelo Zecchin; Joseani Morari; Marcos R Chiaratti; Maria Tereza Santos Correia; Luana Cassandra B Barroso Coelho; Patrícia Maria Guedes Paiva
Journal:  Mol Cell Biochem       Date:  2010-04-30       Impact factor: 3.396

Review 3.  The inflammatory response triggered by Influenza virus: a two edged sword.

Authors:  Luciana P Tavares; Mauro M Teixeira; Cristiana C Garcia
Journal:  Inflamm Res       Date:  2016-10-15       Impact factor: 4.575

4.  Regulation of dendritic cell interleukin-12 secretion by tumour cell necrosis.

Authors:  H Kandil; V Bachy; D J Williams; R Helmi; F M Gotch; M A A Ibrahim
Journal:  Clin Exp Immunol       Date:  2005-04       Impact factor: 4.330

5.  Novel innate immune functions for galectin-1: galectin-1 inhibits cell fusion by Nipah virus envelope glycoproteins and augments dendritic cell secretion of proinflammatory cytokines.

Authors:  Ernest L Levroney; Hector C Aguilar; Jennifer A Fulcher; Luciana Kohatsu; Karen E Pace; Mabel Pang; Kevin B Gurney; Linda G Baum; Benhur Lee
Journal:  J Immunol       Date:  2005-07-01       Impact factor: 5.422

6.  The detrimental effects of IFN-α on vasculogenesis in lupus are mediated by repression of IL-1 pathways: potential role in atherogenesis and renal vascular rarefaction.

Authors:  Seth G Thacker; Celine C Berthier; Deborah Mattinzoli; Maria Pia Rastaldi; Matthias Kretzler; Mariana J Kaplan
Journal:  J Immunol       Date:  2010-08-30       Impact factor: 5.422

Review 7.  Inflammasomes and anti-viral immunity.

Authors:  Vijay A K Rathinam; Katherine A Fitzgerald
Journal:  J Clin Immunol       Date:  2010-07-28       Impact factor: 8.317

8.  IL-1 acts directly on CD4 T cells to enhance their antigen-driven expansion and differentiation.

Authors:  Shlomo Z Ben-Sasson; Jane Hu-Li; Juan Quiel; Stephane Cauchetaux; Maya Ratner; Ilana Shapira; Charles A Dinarello; William E Paul
Journal:  Proc Natl Acad Sci U S A       Date:  2009-04-09       Impact factor: 11.205

9.  Toll/Interleukin-1 Receptor Domain Derived from TcpC (TIR-TcpC) Ameliorates Experimental Autoimmune Arthritis by Down-modulating Th17 Cell Response.

Authors:  Shweta Pasi; Ravi Kant; Avadhesha Surolia
Journal:  J Biol Chem       Date:  2016-03-28       Impact factor: 5.157

10.  Recirculating IL-1R2+ Tregs fine-tune intrathymic Treg development under inflammatory conditions.

Authors:  Eirini Nikolouli; Yassin Elfaki; Susanne Herppich; Carsten Schelmbauer; Michael Delacher; Christine Falk; Ilgiz A Mufazalov; Ari Waisman; Markus Feuerer; Jochen Huehn
Journal:  Cell Mol Immunol       Date:  2020-01-27       Impact factor: 11.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.